CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

All Therapeutic Areas
🫁

Respiratory

112 drugs in pipeline from 10 companies

112

Drugs in Pipeline

10

Companies

10

Upcoming Catalysts

112

Phase 3 Trials

Upcoming Catalysts
2d
days
MRKPhase 2

lenvatinib Phase 2 Results Expected

Lenvatinib315
Apr 20
CT.gov
00%
2d
days
MRKPhase 2

pembrolizumab Phase 2 Results Expected

pembrolizumab315
Apr 20
CT.gov
00%
2w
INSMPDUFA
Phase 2Approved

FDA PDUFA Date Arikayce (priority)

Arikayce™
Apr 28
SEC
2w
VRNAPhase 2

Ensifentrine 3 mg Phase 2 Results Expected

Ensifentrine 3 mg480
Apr 29
CT.gov
00%
2w
VRNAPhase 2

Glycopyrrolate 21.25 mcg Phase 2 Results Expected

Glycopyrrolate 21.25 mcg480
Apr 29
CT.gov
00%
2w
AZNCFPhase 2

Tozorakimab Phase 2 Results Expected

Tozorakimab98
Apr 30
CT.gov
00%
2w
VRTXPhase 3

IVA Phase 3 Results Expected

IVA71
Apr 30
CT.gov
00%
2w
VRTXPhase 3
Positive

ELX/TEZ/IVA Phase 3 Results Expected

ELX/TEZ/IVA71
Apr 30
CT.gov
4w
CLCSPhase 2

mesenchymal stem cells Phase 2 Results Expected

mesenchymal stem cells80
May 10
CT.gov
00%
4w
REGNPhase 2

Pemetrexed Phase 2 Results Expected

Pemetrexed180
May 13
CT.gov
00%
Pipeline by Phase
Phase 3
112